A Boost for Pain Relief
Posted on: Saturday, 17 January 2004, 06:00 CST
Glucosamine increases ibuprofen's ability to ease aches
HealthDayNews -- The nutritional supplement glucosamine helps increase the pain-relieving power of ibuprofen, according to a Temple University study.
This combination may let patients take lower doses of ibuoprofen to get the same amount of pain relief with fewer side effects.
Glucosamine occurs naturally in the body. A synthetic version is used to treat osteoarthritis, a painful, degenerative joint disorder. While glucosamine is believed to prevent and repair bone and cartilage damage, it hasn't yet been proven to block pain.
In this study, the Temple researchers confirmed that glucosamine on its own does not block pain. The researchers believe that any pain relief offered by glucosamine is a side effect of its ability to repair damage to bone and cartilage.
They also tested glucosamine in combination with a variety of non-steroidal anti-inflammatory drugs (NSAIDS) to determine if glucosamine improved the drugs' ability to relieve pain. They found that glucosamine did increase the pain-relieving powers of ibuprofen.
"The next step will be to study this drug combination in clinical trials to see whether it can enhance pain relief or offer pain relief using a lower dose of ibuprofen and therefore a lower risk of side effects," researcher Alan Cowan says in a prepared statement.
The study appeared in a recent issue of the Journal of Pharmacology and Experimental Therapeutics.
-----
On the Net:
More science, space, and technology from RedNova
Copyright © 2003 HealthDay. All rights reserved. The information contained above is intended for general reference purposes only. It is not a substitute for professional medical advice or a medical exam. Always seek the advice of your physician or other qualified health professional before starting any new treatment. Medical information changes rapidly and while Yahoo and its content providers make efforts to update the content on the site, some information may be out of date. No health information on Yahoo, including information about herbal therapies and other dietary supplements, is regulated or evaluated by the Food and Drug Administration and therefore the information should not be used to diagnose, treat, cure or prevent any disease without the supervision of a medical doctor.
Related Articles
- GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer
- Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer
- Scolr Pharma Reports Positive Results From Phase III Pain Study
- Array BioPharma Reports Positive Results From Phase II Dental Pain Study
- Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
- Nutra Pharma Announces Positive Results of ReceptoPharm Pain Study
- Annual Study Finds Top Hospitals Have 28% Lower Mortality Rate
- EDAP TMS S.A. Adds to Clinical Depth; Recent Studies Confirm Repeatability of Outcomes, Lower Side Effects for Ablatherm-HIFU
- Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Pain Study
- Symbollon Provides Update on IoGen Phase III Pain Study
User Comments (0)


RSS Feeds